Sign in

CIK 0001638287

  • Non-accelerated filer
  • Smaller reporting company

MetaVia Inc.

Sign in to watch
Ticker
MTVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472389984
Phone
+1 857-702-9600
Business address
545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
Former names
NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 19 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-08-10 MATHIESEN JEFFREY S Chief Financial Officer Option exercise +3,000 $3.59 $11K 10,927
2017-08-10 MATHIESEN JEFFREY S Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −3,000 45,093
2017-08-10 MATHIESEN JEFFREY S Chief Financial Officer Option exercise +3,000 $3.59 $11K 10,927
2017-08-10 MATHIESEN JEFFREY S Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −3,000 0
2017-07-31 Bisgaier Charles PhD Chief Scientific Off. & Chair Option exercise +4,474 $1.34 $6K 1,248,914
2017-07-31 Bisgaier Charles PhD Chief Scientific Off. & Chair Option exercise · Employee Stock Option (right to buy) −4,474 0
2017-05-30 Gullans Steven R. Ph.D. Interim President & CEO Grant or award · Employee Stock Option (right to buy) +60,000 60,000
2017-03-28 Golden Lee Scott Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +20,000 20,000
2017-03-10 SASSINE ANDY Director Purchase +21,119 $9.47 $200K 136,264
2017-03-10 SASSINE ANDY Director Purchase · Warrant to Purchase Common Stock +15,840 $9.47 $150K 15,840
2017-03-10 LICHTINGER PEDRO Director Purchase +10,559 $9.47 $100K 59,833
2017-03-10 LICHTINGER PEDRO Director Purchase · Warrant to Purchase Common Stock +7,920 $9.47 $75K 7,920
2017-03-10 Hawryluk P. Kent Director Purchase +25,000 $9.47 $237K 81,889
2017-03-10 Hawryluk P. Kent Director Purchase · Warrant to Purchase Common Stock +18,750 $9.47 $178K 18,750
2017-03-10 Gullans Steven R. Ph.D. Director Purchase +52,798 $9.47 $500K 858,823
2017-03-10 Gullans Steven R. Ph.D. Director Purchase · Warrant to Purchase Common Stock +39,599 $9.47 $375K 39,599
2017-02-01 KOUSKY KENNETH W Director Other disposition −101,406 4,472
2017-02-01 KOUSKY KENNETH W Director Other disposition −110,428 6,463
2016-11-25 Sooch Mina President & CEO Grant or award · Employee Stock Option (right to buy) +120,000 600,000
2016-10-05 Golden Lee Scott Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +126,000 126,000

Page 6 of 7 · 135 trades